NCT01606033 2026-03-13
IPSY
Centre Oscar Lambret
Phase NA Completed
Clinical Trials
15 trialsNCT05879133 2026-03-04
HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT05108298 2026-03-02
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Eastern Cooperative Oncology Group
Phase NA Recruiting
NCT01949662 2026-02-13
Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04401267 2025-11-03
Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma
St. Jude Children's Research Hospital
Phase 2 Completed
NCT05641961 2025-07-23
Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
University of California, San Francisco
Phase NA Recruiting
NCT06138145 2025-04-18
Inclusion Appeal Videos and Intent to Register for Pediatric Clinical Trials
University of Pennsylvania
Phase NA Completed
NCT04870320 2022-04-08
Study of Attention and Memory Treatments for Cancer Survivors
University of California, San Francisco
Phase NA Completed
NCT03943082 2021-11-16
Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials
University of California, San Francisco
Phase NA Terminated
NCT02948283 2021-02-12
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 1 Completed
NCT02730884 2020-08-07
Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02225574 2020-02-12
An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T)
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT01875237 2019-07-16
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT02473523 2017-03-08
Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia
St. Jude Children's Research Hospital
Phase NA Terminated
NCT00502749 2011-10-17
Exercise Program for Adolescents and Young Adults With Cancer
M.D. Anderson Cancer Center
Phase NA Completed